Tag: ibalizumab

September 14, 2018

European Medicines Agency Validates Marketing Authorization Application for Trogarzo

Theratechnologies (TSX:TH) is pleased to announce that the European Medicines Agency has confirmed the validity of the marketing authorization application...
March 7, 2018

Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo

Theratechnologies (TSX:TH) and its partner TaiMed Biologics, announced that the U.S. Food and Drug Administration (FDA) has granted approval of...
February 7, 2018

Theratechnologies Announces Financial Results for Fiscal Year 2017

Theratechnologies (TSX:TH) announced its financial results for the year ended November 30, 2017. As quoted in the press release: Selling...
February 5, 2018

5 Pharmaceutical Stocks on the TSX and TSXV

Opportunities abound when it comes to TSX pharmaceutical stocks, particularly those of the nano or micro cap variety, we're profiling...
January 8, 2018

Top Pharma Stocks of 2017

INN has compiled a list of the top performing pharma stocks of 2017.
October 4, 2017

Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™

Theratechnologies (TSX:TH) has announced 48-week efficacy and safety results for ibalizumab in patients infected with multidrug resistant HIV-1 that completed...
September 18, 2017

Theratechnologies to Present Safety and Efficacy Data of Ibalizumab

Theratechnologies announced the presentation of abstract on safety data from Ibalizumab at an upcoming conference.